ATE491953T1 - Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis - Google Patents

Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Info

Publication number
ATE491953T1
ATE491953T1 AT04788750T AT04788750T ATE491953T1 AT E491953 T1 ATE491953 T1 AT E491953T1 AT 04788750 T AT04788750 T AT 04788750T AT 04788750 T AT04788750 T AT 04788750T AT E491953 T1 ATE491953 T1 AT E491953T1
Authority
AT
Austria
Prior art keywords
diagnosis
cytokint
ankyloid
spondylitis
assessment
Prior art date
Application number
AT04788750T
Other languages
English (en)
Inventor
Cherie Chappell
Michael Centola
Philip Alex
Kenneth Hensley
Original Assignee
Oklahoma Med Res Found
Univ Oklahoma State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found, Univ Oklahoma State filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE491953T1 publication Critical patent/ATE491953T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04788750T 2003-09-15 2004-09-15 Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis ATE491953T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50313103P 2003-09-15 2003-09-15
PCT/US2004/030059 WO2005029091A2 (en) 2003-09-15 2004-09-15 Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases

Publications (1)

Publication Number Publication Date
ATE491953T1 true ATE491953T1 (de) 2011-01-15

Family

ID=34375314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04788750T ATE491953T1 (de) 2003-09-15 2004-09-15 Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Country Status (8)

Country Link
US (4) US20060094056A1 (de)
EP (4) EP1664796B1 (de)
JP (1) JP4711963B2 (de)
AT (1) ATE491953T1 (de)
AU (3) AU2004274909B8 (de)
CA (1) CA2537818A1 (de)
DE (1) DE602004030586D1 (de)
WO (1) WO2005029091A2 (de)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011940B1 (en) * 1999-04-14 2006-03-14 Medical Discovery Partners Llc Quality control for cytochemical assays
DK1882946T3 (da) * 2003-12-23 2010-05-31 Hoffmann La Roche Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
US20070141723A1 (en) * 2005-12-16 2007-06-21 Sompuram Seshi A Immunohistochemistry staining controls
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
JP4734647B2 (ja) * 2006-08-02 2011-07-27 国立大学法人金沢大学 胸腺腫合併重症筋無力症の診断方法
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2008133641A2 (en) * 2006-10-11 2008-11-06 Curagen Corporation Antibodies directed to gpnmb and uses thereof
CA2703124C (en) * 2006-10-25 2017-06-13 Chu Sainte-Justine Methods for diagnosing osteoarthritis
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
CA2667012A1 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US20100178652A1 (en) * 2007-01-05 2010-07-15 Litherland Sally A Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
WO2008104608A1 (en) * 2007-03-01 2008-09-04 Universite Catholique De Louvain Method for the determination and the classification of rheumatic conditions
GB0707933D0 (en) * 2007-04-24 2007-05-30 Apitope Technology Bristol Ltd Disease markers
US7709215B2 (en) * 2007-06-01 2010-05-04 Cytonics Corporation Method for diagnosing and treating acute joint injury
CN101932935A (zh) * 2007-06-20 2010-12-29 先灵公司 用于炎性关节病抗白介素-17a治疗的关节破坏生物标记
US20100261613A1 (en) * 2007-07-26 2010-10-14 Michael Centola Methods for inflammatory disease management
CA2710035C (en) * 2007-12-21 2018-01-16 Mcmaster University Method for assessing risk of heart failure
CN101960021A (zh) 2008-02-28 2011-01-26 希森美康株式会社 产生il-17的辅助t细胞检测用标记及产生il-17的辅助t细胞的检测方法
US20100255467A1 (en) * 2008-07-22 2010-10-07 Los Alamos National Security, Llc Assays for determining exposure to multiwalled carbon nanotubes
GB2464183A (en) * 2008-09-19 2010-04-14 Singulex Inc Sandwich assay
FI20086145A0 (fi) * 2008-12-01 2008-12-01 Kansanterveyslaitos Menetelmä autoimmuunisairauksien osoittamiseksi
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
KR20110110247A (ko) * 2008-12-30 2011-10-06 센토코 오르토 바이오테크 인코포레이티드 강직성 척추염 환자에서 항-ＴＮＦα 항체에 대한 임상적 반응을 예측하는 혈청 마커
EP2396652B1 (de) 2009-02-11 2017-12-13 Cedars-Sinai Medical Center Diagnose chronisch entzündlicher darmerkrankungen mittels cytolethal distending toxin
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
EP2445517B1 (de) * 2009-06-25 2014-07-30 Nestec S.A. Verfahren zur diagnostizierung des reizdarmsyndroms
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
JP5858785B2 (ja) 2009-07-29 2016-02-10 シスメックス株式会社 ヒトｉｌ−１７産生ヘルパーｔ細胞検出用マーカーおよび試薬、並びにヒトｉｌ−１７産生ヘルパーｔ細胞の検出方法
WO2011028945A1 (en) 2009-09-03 2011-03-10 Genentech, Inc. Methods for treating, diagnosing, and monitoring rheumatoid arthritis
WO2011047358A1 (en) * 2009-10-15 2011-04-21 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
US20120208719A1 (en) * 2009-10-16 2012-08-16 Mayo Foundation For Medical Education And Research Assessing rheumatoid arthritis
KR101178217B1 (ko) * 2009-10-28 2012-09-07 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
JP5275211B2 (ja) * 2009-12-16 2013-08-28 猛夫 吉野内 間質性肺炎判定マーカーによる判定法
EP2336769A1 (de) * 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden
US20110250206A1 (en) 2010-02-11 2011-10-13 Axtell Robert C Markers for determination of patient responsiveness
WO2011137306A1 (en) * 2010-04-30 2011-11-03 University Of Virginia Patent Foundation System, method and computer program product for the organism-specific diagnosis of septicemia in infants
WO2011140484A1 (en) * 2010-05-06 2011-11-10 Singulex, Inc Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
ES2609931T3 (es) * 2010-06-18 2017-04-25 Myriad Genetics, Inc. Métodos y materiales para evaluar la pérdida de heterocigosidad
IN2013CN01129A (de) * 2010-07-14 2015-07-31 Commw Scient Ind Res Org
US20130217656A1 (en) * 2010-08-12 2013-08-22 Beth Israel Deaconess Medical Center Inc Methods and compositions for diagnosing and treating lupus
US20130303391A1 (en) * 2010-09-14 2013-11-14 Oklahoma Medical Research Foundation Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
WO2012051317A1 (en) * 2010-10-12 2012-04-19 Epicgenetics, Llc Method for diagnosing and treating fibromyalgia
WO2012097207A2 (en) * 2011-01-13 2012-07-19 The Johns Hopkins University Cytokine profiles as methods for diagnosis and prognosis of irritable bowel syndrome
JP5946605B2 (ja) 2011-01-28 2016-07-06 シスメックス株式会社 ヒトｉｌ−１７産生ヘルパーｔ細胞の検出方法
US9946836B2 (en) * 2011-01-31 2018-04-17 Robert Bosch Gmbh Biomarker monitoring device and method
EP2673372A4 (de) * 2011-02-10 2014-11-19 Genqual Corp Verfahren zur prognose und verabreichung einer behandlung von entzündlichen erkrankungen
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
WO2013052844A1 (en) 2011-10-07 2013-04-11 Pulmatrix, Inc. Methods for treating and diagnosing respiratory tract infections
EP2823311B1 (de) * 2012-03-06 2016-04-27 Life Technologies Corporation Biomarker für systemischer lupus erythematodes
US20150141332A1 (en) * 2012-06-04 2015-05-21 Biomet Biologics, Llc Methods for diagnosing osteoarthritis
ES2859522T3 (es) * 2012-07-13 2021-10-04 Univ Pennsylvania Control de la toxicidad para la actividad antitumoral de CAR
JP6401702B2 (ja) 2012-09-07 2018-10-10 ザ・ガバナーズ・オブ・ザ・ユニバーシティー オブ・アルバータ 炎症性肝疾患の診断のための方法および組成物
ES2646598T3 (es) 2012-09-17 2017-12-14 Cedars-Sinai Medical Center Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia
WO2014081974A1 (en) * 2012-11-21 2014-05-30 Massachusetts Institute Of Technology Biomarkers for dengue fever and use thereof
GB201223223D0 (en) 2012-12-21 2013-02-06 Norinnova Technology Transfer As Inflammatory bowel disease
CN107430118A (zh) * 2013-06-27 2017-12-01 广东盛泽康华生物医药有限公司 对自身免疫状况的分类与管理的方法与仪器
EP3693738A1 (de) * 2013-09-20 2020-08-12 Astute Medical, Inc. Verfahren und zusammensetzungen zur diagnose und prognose von appendizitis und differenzierung von ursachen für bauchschmerzen
AU2014329535B2 (en) 2013-10-03 2017-09-07 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
PL3054977T3 (pl) * 2013-10-09 2021-12-20 Cedars-Sinai Medical Center Diagnoza i leczenie zespołu jelita drażliwego i choroby zapalnej jelit
JP6220222B2 (ja) 2013-10-28 2017-10-25 シスメックス株式会社 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品
CA2943821A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
WO2015191613A1 (en) 2014-06-10 2015-12-17 Crescendo Bioscience Biomarkers and methods for measuring and monitoring axial spondyloarthritis disease activity
MX2017001011A (es) 2014-07-21 2018-05-28 Novartis Ag Tratamiento de cancer de usando un receptor quimerico de antigeno anti-bcma.
AU2015292811B2 (en) 2014-07-21 2019-12-19 Novartis Ag Treatment of cancer using a CLL-1 chimeric antigen receptor
SG11201702475VA (en) * 2014-09-26 2017-04-27 Univ Singapore Methods and compositions for modulating th-gm cell function
CA2962493C (en) 2014-10-09 2023-01-10 Cedars-Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
MX2017004816A (es) * 2014-10-20 2017-08-02 Nestec Sa Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
US10039808B2 (en) * 2014-10-22 2018-08-07 Michael Chez Method of treating or improving neurological function in a human subject
CN104434841B (zh) * 2014-12-11 2017-06-06 顺昊细胞生物技术（天津）股份有限公司 一种结肠定位复合细胞因子组合物
US10408844B2 (en) 2015-01-28 2019-09-10 The Governors Of The University Of Alberta Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
US9925244B1 (en) 2015-02-17 2018-03-27 Michael Chez Treatment of warts in non-immunosuppressed patients
JP6531306B2 (ja) * 2015-02-20 2019-06-19 一三 西野 炎症性筋疾患鑑別マーカー及びそれを用いた炎症性筋疾患と非炎症性筋疾患の鑑別方法
US10429379B2 (en) 2015-05-12 2019-10-01 The General Hospital Corporation Autoantigens for diagnosis of rheumatoid arthritis
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
WO2017042381A1 (en) * 2015-09-11 2017-03-16 Vib Vzw Means and methods for diagnosing familial mediterranean fever
JP6565099B2 (ja) * 2015-09-18 2019-08-28 国立大学法人 長崎大学 家族性地中海熱のバイオマーカー
WO2017059003A1 (en) 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing psoriatic arthritis disease activity
WO2017058999A2 (en) 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
WO2017214180A1 (en) 2016-06-07 2017-12-14 The General Hospital Corporation Identification of a t cell epitope of prevotella copri that induces t cell responses in patients with rheumatoid arthritis
US20200080987A1 (en) * 2016-10-25 2020-03-12 Eccrine Systems, Inc. Biofluid sensing device cytokine measurement
CA3064529C (en) * 2017-05-31 2021-12-14 Prometheus Biosciences, Inc. Methods for assessing mucosal healing in crohn's disease patients
SG11202011830SA (en) 2018-06-13 2020-12-30 Novartis Ag Bcma chimeric antigen receptors and uses thereof
WO2020092443A1 (en) * 2018-10-29 2020-05-07 Thomas Jefferson University Compositions and methods for discriminating infectious from non-infectious cns disorders
WO2021039771A1 (ja) * 2019-08-29 2021-03-04 国立大学法人東北大学 炎症性腸疾患の診断方法、診断プローブ及び診断キット
KR102242286B1 (ko) * 2019-10-02 2021-04-20 코아스템(주) 중간엽줄기세포의 신장섬유화 치료효과 예측용 바이오마커 조성물
KR102242285B1 (ko) * 2019-10-02 2021-04-20 코아스템(주) 중간엽줄기세포의 전신홍반루푸스 치료효과 예측용 바이오마커 조성물
JP2023506253A (ja) * 2019-12-16 2023-02-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 神経筋障害を治療するため組成物及び方法
RU2743748C1 (ru) * 2020-06-04 2021-02-25 Светлана Владимировна Панова Способ ранней диагностики болезни бехтерева в оториноларингологии
CN113834940A (zh) * 2021-09-24 2021-12-24 四川大学华西医院 间质性膀胱炎/膀胱疼痛综合征诊断试剂盒
EP4361633A1 (de) * 2022-10-25 2024-05-01 Peptomyc, S.L. Verfahren zur vorhersage der reaktion auf eine krebsbehandlung

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
WO1990007332A1 (en) 1986-04-25 1990-07-12 Hitoshi Shichi Immunosuppressive agent
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5294698A (en) 1990-12-06 1994-03-15 Bomalaski John S Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
ATE184703T1 (de) 1991-07-19 1999-10-15 Cytimmune Sciences Inc Verfahren und testsatz zur messung von endogenen zytokinen
US5965379A (en) 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
AU5542794A (en) * 1992-10-29 1994-05-24 Miles Inc. Diagnostic assay for latent matrix metalloproteinase no. 9
US5646005A (en) * 1994-04-28 1997-07-08 Kudsk; Kenneth A. Use of an IL-6 assay for predicting the development of post-trauma complications
US5658744A (en) 1994-07-22 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying patients having an altered immune status
US5599795A (en) 1994-08-19 1997-02-04 Mccann; Michael Method for treatment of idiopathic inflammatory bowel disease (IIBD)
JPH08151373A (ja) * 1994-09-30 1996-06-11 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｅｉ−１５１１類およびｅｉ−１６２５−２
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5753442A (en) 1995-09-01 1998-05-19 Cedars-Sinai Medical Center Method for determining genetic predisposition for seronegative spondyloarthropathies and products useful therefor
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US6183951B1 (en) 1997-04-11 2001-02-06 Prometheus Laboratories, Inc. Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy
US6555320B1 (en) * 1998-09-01 2003-04-29 Mayo Foundation For Medical Education And Research Methods and materials for evaluating rheumatoid arthritis
US6406884B1 (en) 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
US6020165A (en) * 1998-11-10 2000-02-01 Incyte Pharmaceuticals, Inc. Cytikine signal regulators
US6162604A (en) * 1999-04-01 2000-12-19 Jacob; Chaim O. Methods for determining genetic predisposition to autoimmune diseases by genotyping apoptotic genes
EP1109206B1 (de) * 1999-12-16 2007-08-29 Infineon Technologies AG Prozessanlage und Prozessverfahren zur Montage von Leadframes
GB0001448D0 (en) * 2000-01-21 2000-03-08 Novartis Ag Organic compounds
WO2001067103A1 (en) * 2000-03-06 2001-09-13 Bioseek, Inc. Function homology screening
US8153121B2 (en) 2000-10-06 2012-04-10 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
JP2005503533A (ja) * 2001-01-19 2005-02-03 ケンブリッジ サイエンティフィック， インコーポレイテッド 骨粗鬆症の診断方法および処置方法
US20030017493A1 (en) 2001-06-20 2003-01-23 Marc Fremont Methods for the detection and treatment of chronic immune diseases
US6989239B2 (en) 2001-06-20 2006-01-24 R.E.D. Laboratories, N.V./S.A. Methods for diagnosis and treatment of chronic immune diseases
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
GB0224415D0 (en) * 2002-10-21 2002-11-27 Medical Res Council Compositions
US6919483B2 (en) * 2003-05-23 2005-07-19 Mediquest Therapeutics, Inc. Immunomodulation with novel pharmaceutical compositions
GB0407315D0 (en) * 2003-07-15 2004-05-05 Cambridge Antibody Tech Human antibody molecules
US7928132B2 (en) * 2004-08-06 2011-04-19 Ohio University Methods for the amelioration of episodes of acute or chronic ulcerative colitis

Also Published As

Publication number Publication date
AU2004274909B8 (en) 2010-06-10
EP1664796A2 (de) 2006-06-07
AU2010201817A1 (en) 2010-05-27
EP2280285A1 (de) 2011-02-02
EP2287616A1 (de) 2011-02-23
JP2007506100A (ja) 2007-03-15
AU2004274909B2 (en) 2010-02-11
AU2010201817B2 (en) 2012-02-02
US20120258883A1 (en) 2012-10-11
US20140005071A1 (en) 2014-01-02
DE602004030586D1 (de) 2011-01-27
JP4711963B2 (ja) 2011-06-29
CA2537818A1 (en) 2005-03-31
AU2004274909A1 (en) 2005-03-31
EP1664796B1 (de) 2010-12-15
EP2280286A1 (de) 2011-02-02
AU2010201818A1 (en) 2010-05-27
US20060094056A1 (en) 2006-05-04
US20090325167A1 (en) 2009-12-31
WO2005029091A2 (en) 2005-03-31
WO2005029091A3 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
ATE510208T1 (de) Probenanalyseverfahren und probenanalyseeinrichtung
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
JP2005509161A5 (de)
JP2010535544A5 (de)
ATE361470T1 (de) Verfahren zur diagnose von immunologischer lebensmittelsensitivität
ATE427067T1 (de) Verfahren zur detektierung von temperaturanderungen
ATE319999T1 (de) Verfahren und system zum feststellen der akzeptabilität von signaldaten, die von einem prothrombin zeitteststreifen gesammelt sind
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
EA200701744A1 (ru) Оценка шума на одной частоте посредством замера шума на других частотах
ATE426175T1 (de) Verfahren zur standardisierung von gerinnungstesten
EP1359422A3 (de) Mikroarray mit strukturierten und unstrukturierten Sonden
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
EA202192954A1 (ru) Электрохимическое измерение d-лактата для диагностики и прогнозирования инфекционного заболевания
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
FR2900746B1 (fr) Procede et dispositif de diagnostic d'un mecanisme.
DE602004013554D1 (de) Verbindungen und verfahren zur diagnose von prostatakrebs
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
JP2018072313A5 (de)
ATE261120T1 (de) Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties